BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38279420)

  • 1. Anti-cancer activity of microbubble conjugated with Sorafenib containing liposome and IL4R-targeting peptide in kidney cancer cells.
    Lee J; Park SH
    Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):266-271. PubMed ID: 38279420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a novel microbubble-liposome complex conjugated with peptide ligands targeting IL4R on brain tumor cells.
    Park SH; Yoon YI; Moon H; Lee GH; Lee BH; Yoon TJ; Lee HJ
    Oncol Rep; 2016 Jul; 36(1):131-6. PubMed ID: 27220374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound-mediated gene and drug delivery using a microbubble-liposome particle system.
    Yoon YI; Kwon YS; Cho HS; Heo SH; Park KS; Park SG; Lee SH; Hwang SI; Kim YI; Jae HJ; Ahn GJ; Cho YS; Lee H; Lee HJ; Yoon TJ
    Theranostics; 2014; 4(11):1133-44. PubMed ID: 25250094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gefitinib/chloroquine-liposome-microbubble complexes as ultrasound-triggered therapeutic particles for head and neck squamous cell carcinoma in vitro].
    Zhou L; Gong X; Xiong P
    Shanghai Kou Qiang Yi Xue; 2020 Apr; 29(2):168-173. PubMed ID: 32626880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast-enhanced ultrasound combined targeted microbubbles for diagnosis of highly aggressive papillary thyroid carcinoma.
    Ma J; Wang Y; Xi X; Tang J; Wang L; Wang L; Wang D; Liang X; Zhang B
    Front Endocrinol (Lausanne); 2023; 14():1052862. PubMed ID: 36936158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted shRNA-loaded liposome complex combined with focused ultrasound for blood brain barrier disruption and suppressing glioma growth.
    Zhao G; Huang Q; Wang F; Zhang X; Hu J; Tan Y; Huang N; Wang Z; Wang Z; Cheng Y
    Cancer Lett; 2018 Apr; 418():147-158. PubMed ID: 29339208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STAT3 decoy oligonucleotide-carrying microbubbles with pulsed ultrasound for enhanced therapeutic effect in head and neck tumors.
    Ramasamy T; Chen X; Qin B; Johnson DE; Grandis JR; Villanueva FS
    PLoS One; 2020; 15(11):e0242264. PubMed ID: 33206698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RIPL peptide (IPLVVPLRRRRRRRRC)-conjugated liposomes for enhanced intracellular drug delivery to hepsin-expressing cancer cells.
    Kang MH; Park MJ; Yoo HJ; hyuk KY; Lee SG; Kim SR; Yeom DW; Kang MJ; Choi YW
    Eur J Pharm Biopharm; 2014 Aug; 87(3):489-99. PubMed ID: 24704199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sorafenib-Loaded Long-Circulating Nanoliposomes for Liver Cancer Therapy.
    Ye H; Zhou L; Jin H; Chen Y; Cheng D; Jiang Y
    Biomed Res Int; 2020; 2020():1351046. PubMed ID: 32461962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasound-Guided Delivery of siRNA and a Chemotherapeutic Drug by Using Microbubble Complexes: In Vitro and In Vivo Evaluations in a Prostate Cancer Model.
    Bae YJ; Yoon YI; Yoon TJ; Lee HJ
    Korean J Radiol; 2016; 17(4):497-508. PubMed ID: 27390541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined treatment of sorafenib and doxorubicin-loaded microbubble-albumin nanoparticle complex for hepatocellular carcinoma: A feasibility study.
    Lee S; Kim JH; Moon H; Lee HJ; Han JK
    PLoS One; 2020; 15(12):e0243815. PubMed ID: 33306731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Release of vascular agonists from liposome-microbubble conjugate by ultrasound-mediated microbubble destruction: effect on vascular function.
    Franco-Urquijo CA; Navarro-Becerra JÁ; Ríos A; Escalante B
    Drug Deliv Transl Res; 2022 May; 12(5):1175-1186. PubMed ID: 33939122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic Targeting and Ultrasound Activation of Liposome-Microbubble Conjugate for Enhanced Delivery of Anticancer Therapies.
    Dwivedi P; Kiran S; Han S; Dwivedi M; Khatik R; Fan R; Mangrio FA; Du K; Zhu Z; Yang C; Huang F; Ejaz A; Han R; Si T; Xu RX
    ACS Appl Mater Interfaces; 2020 May; 12(21):23737-23751. PubMed ID: 32374147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of sorafenib-loaded poly (lactic/glycolic) acid and DPPC liposome nanoparticles in the in vitro treatment of renal cell carcinoma.
    Liu J; Boonkaew B; Arora J; Mandava SH; Maddox MM; Chava S; Callaghan C; He J; Dash S; John VT; Lee BR
    J Pharm Sci; 2015 Mar; 104(3):1187-96. PubMed ID: 25573425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted contrast-enhanced ultrasound imaging of tumor angiogenesis with contrast microbubbles conjugated to integrin-binding knottin peptides.
    Willmann JK; Kimura RH; Deshpande N; Lutz AM; Cochran JR; Gambhir SS
    J Nucl Med; 2010 Mar; 51(3):433-40. PubMed ID: 20150258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor hypoxia directed multimodal nanotherapy for overcoming drug resistance in renal cell carcinoma and reprogramming macrophages.
    Alsaab HO; Sau S; Alzhrani RM; Cheriyan VT; Polin LA; Vaishampayan U; Rishi AK; Iyer AK
    Biomaterials; 2018 Nov; 183():280-294. PubMed ID: 30179778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel-liposome-microbubble complexes as ultrasound-triggered therapeutic drug delivery carriers.
    Yan F; Li L; Deng Z; Jin Q; Chen J; Yang W; Yeh CK; Wu J; Shandas R; Liu X; Zheng H
    J Control Release; 2013 Mar; 166(3):246-55. PubMed ID: 23306023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary antioxidant quercetin overcomes the acquired resistance of Sorafenib in Sorafenib-resistant hepatocellular carcinoma cells through epidermal growth factor receptor signaling inactivation.
    Zhang Z; Wu H; Zhang Y; Shen C; Zhou F
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jan; 397(1):559-574. PubMed ID: 37490119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic ultrasonic microbubbles carrying paclitaxel and LyP-1 peptide: preparation, characterization and application to ultrasound-assisted chemotherapy in breast cancer cells.
    Yan F; Li X; Jin Q; Jiang C; Zhang Z; Ling T; Qiu B; Zheng H
    Ultrasound Med Biol; 2011 May; 37(5):768-79. PubMed ID: 21458148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor effects of a combination of interferon-alpha and sorafenib on human renal carcinoma cell lines.
    Tochizawa S; Masumori N; Yanai Y; Ohmoto Y; Yabuuchi Y; Tsukamoto T
    Biomed Res; 2008 Dec; 29(6):271-8. PubMed ID: 19129670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.